Literature DB >> 26181871

Sinusoidal obstructive syndrome with hypereosinophilia successfully treated with prednisolone.

Yuichi Yamaga1,2, Yukio Tsugihashi3, Takefumi Nakamura4, Takanori Taniguchi5, Gen Honjou6, Masayoshi Kage7.   

Abstract

A 60-year-old man was admitted to Tenri Hospital complaining of erythema and abdominal distention. There were marked liver damage and hypereosinophilia. The patient was suffering from portal hypertension and coagulation disorder. We diagnosed the patient clinically as suffering from veno-occlusive disease, or sinusoidal obstructive syndrome (SOS). The pathological finding of the liver biopsy specimen was compatible with SOS. All of the manifestations, liver function test, and hemodynamics subsided shortly after administration of steroid treatment and ursodeoxycholic acid. The pathogenesis was not identified but some allergic reaction was suspected.

Entities:  

Keywords:  Eosinophil; Portal hypertension; Sinusoidal obstructive syndrome (SOS); Sonazoid; Steroid; Veno-occlusive disease (VOD)

Year:  2011        PMID: 26181871     DOI: 10.1007/s12328-011-0264-3

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  12 in total

1.  Veno-occlusive disease in hypereosinophilic syndrome.

Authors:  K Kojima; T Sasaki
Journal:  Intern Med       Date:  1995-12       Impact factor: 1.271

Review 2.  Role of platelets in thrombosis and hemostasis.

Authors:  M A Packham
Journal:  Can J Physiol Pharmacol       Date:  1994-03       Impact factor: 2.273

3.  Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium.

Authors:  E Frigas; D A Loegering; G J Gleich
Journal:  Lab Invest       Date:  1980-01       Impact factor: 5.662

4.  Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils.

Authors:  M P Hallsworth; T M Litchfield; T H Lee
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

5.  Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid-enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model.

Authors:  Shohei Yoshikawa; Hiroko Iijima; Masaki Saito; Hironori Tanaka; Hiroyasu Imanishi; Naoki Yoshimoto; Tomohiro Yoshimoto; Shizue Futatsugi-Yumikura; Kenji Nakanishi; Tohru Tsujimura; Takashi Nishigami; Atsushi Kudo; Shigeki Arii; Shuhei Nishiguchi
Journal:  Hepatol Res       Date:  2010-06-08       Impact factor: 4.288

6.  Increased biosynthesis of platelet-activating factor in activated human eosinophils.

Authors:  T Lee; D J Lenihan; B Malone; L L Roddy; S I Wasserman
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

7.  Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.

Authors:  H M Shulman; L B Fisher; H G Schoch; K W Henne; G B McDonald
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

8.  Veno occlusive disease: update on clinical management.

Authors:  M Senzolo; G Germani; E Cholongitas; P Burra; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

9.  General rules for recording endoscopic findings of esophagogastric varices (2nd edition).

Authors:  Takashi Tajiri; Hiroshi Yoshida; Katsutoshi Obara; Morikazu Onji; Masayoshi Kage; Seigo Kitano; Norihiro Kokudo; Shigehiro Kokubu; Isao Sakaida; Michio Sata; Hisao Tajiri; Kazuhiro Tsukada; Toshiaki Nonami; Makoto Hashizume; Shouzou Hirota; Naoya Murashima; Fuminori Moriyasu; Katsunori Saigenji; Hiroyasu Makuuchi; Kazuhiko Oho; Tomoharu Yoshida; Hiroaki Suzuki; Akitake Hasumi; Kiwamu Okita; Shunji Futagawa; Yasuo Idezuki
Journal:  Dig Endosc       Date:  2010-01       Impact factor: 7.559

10.  Budd-Chiari syndrome associated with hypereosinophilic syndrome; a case report.

Authors:  Ai Inoue; Kojiro Michitaka; Shuichiro Shigematsu; Ichiro Konishi; Masashi Hirooka; Yoichi Hiasa; Hidetaka Matsui; Bunzo Matsuura; Norio Horiike; Takaaki Hato; Hiroaki Miyaoka; Morikazu Onji
Journal:  Intern Med       Date:  2007-07-17       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.